Article info
PDFCorrespondence response
CONCEPT provides robust evidence that chondroitin sulfate is superior to placebo and similar to celecoxib in the symptomatic management of osteoarthritis
- Correspondence to Professor Jean-Yves L Reginster, Department of Public Health, Epidemiology and Health Economics, Liège State University, Liège CHU B23, Belgium; jyreginster{at}ulg.ac.be
Citation
CONCEPT provides robust evidence that chondroitin sulfate is superior to placebo and similar to celecoxib in the symptomatic management of osteoarthritis
Publication history
- Received September 6, 2017
- Revised September 12, 2017
- Accepted September 15, 2017
- First published September 22, 2017.
Online issue publication
January 12, 2018
Article Versions
- Previous version (12 January 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.